3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Phase 3
1
Phase 2
1
Phase 1/2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Leukemia, Myeloid, Acute
22
Leukemia
15
Lymphoma
11
Leukemia, Erythroblastic, Acute
8
Prostatic Neoplasms
7
Leukemia, Myelomonocytic, Acute
7
Leukemia, Monocytic, Acute
7
Leukemia, Megakaryoblastic, Acute
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Lymphoma, Large B-Cell, Diffuse
6
Lymphoma, Follicular
6
Myelodysplastic Syndromes
5
Lymphoma, Non-Hodgkin
5
Lymphoma, Large-Cell, Immunoblastic
5
Anemia, Refractory, with Excess of Blasts
4
Leukemia, Promyelocytic, Acute
3
Congenital Abnormalities
3
Breast Neoplasms
3
Pain
2
Neutropenia
2
Myeloproliferative Disorders
2
Leukemia, Myelomonocytic, Chronic
2
Burkitt Lymphoma
2
Sarcoma, Myeloid
1
Recurrence
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm, Residual
1
Myelodysplastic-Myeloproliferative Diseases
1
Lymphoma, Large-Cell, Anaplastic
1
Interventions
Paclitaxel
20
Gemcitabine
16
Dexamethasone
16
Bevacizumab
16
Docetaxel
15
Oxaliplatin
14
Cyclophosphamide
13
Carboplatin
12
Capecitabine
12
Sorafenib
11
Fluorouracil
11
Leucovorin
10
Cisplatin
10
pembrolizumab
9
Pemetrexed
9
Epoetin Alfa
9
venetoclax
8
Prednisone
8
Fentanyl
8
Drug Therapy
8
Doxorubicin
8
atezolizumab
7
Rivaroxaban
7
Rituximab
7
Darbepoetin alfa
7
Anastrozole
7
Panitumumab
6
Ondansetron
6
Morphine
6
Irinotecan
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Neoplasms
×
Mitoxantrone
×
Clear all
NCT00417079
2011-03-10
TROPIC
Sanofi
Phase 3
Completed
755 enrolled
19 charts